MUSTANG BIO, INC. (MBIO)
About MUSTANG BIO, INC.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2019
- $0
- Net income
- -$1.9M
- Total assets
- $17.6M
- Market cap
- $5.1M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $2.4M
- Operating income
- -$2.4M
- Income tax
- $27.0K
- Net income
- -$1.9M
- EPS (basic)
- $-0.39
- EPS (diluted)
- $-0.39
Balance sheet
- Total assets
- $17.6M
- Current assets
- $17.6M
- Total liabilities
- $8.1M
- Current liabilities
- $7.9M
- Shareholders’ equity
- $9.5M
Cash flow
- Operating cash flow
- -$5.3M
- Investing cash flow
- $1.2M
- Financing cash flow
- $14.5M
- Net cash flow
- $10.4M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $5.1M
- EPS (diluted)
- $-0.39
- Shares outstanding
- 9.1M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Aug 22, 2017
Mustang BIO, Inc. (MBIO) Stock Price
- Reported a net loss of $1.9M in FY2019.
- Trading 83% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review MUSTANG BIO, INC..
Write a review
News about MUSTANG BIO, INC.
News & sentiment via Polygon.io
Mustang BIO, Inc.: frequently asked questions
Is Mustang BIO, Inc. an American company?
Mustang BIO, Inc. is a US-based company headquartered in Waltham, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Mustang BIO, Inc. headquartered?
Mustang BIO, Inc. is headquartered in Waltham, Massachusetts, United States.
Is Mustang BIO, Inc. publicly traded?
Yes — Mustang BIO, Inc. is a publicly traded company. Its stock trades under the ticker symbol MBIO on the NASDAQ.
What does Mustang BIO, Inc. do?
Mustang BIO, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
